Miraculum S.A (MIR) Fair Value & Analysis
Consumer Defensive · PL · Market cap 28.5M PLN
Fair value as of: Jun 24, 2026
From 14 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from 0.4000 PLN to 3.17 PLN (+692.5%) since Jun 23, 2026. Share price −10.7% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.5639 PLN – 0.9483 PLN · fair‑value band 2.38 PLN – 3.96 PLN · the 0.5660 PLN price screens below the 3.17 PLN fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Miraculum S.A (MIR) currently trades at 0.5660 PLN, while our model-based Fair Value estimate is 3.17 PLN — implying the stock looks roughly 460.1% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, Miraculum S.A generated revenue of 53.3M PLN at a net margin of -3.0%. Revenue declined 2.8% year over year. It earns a return on equity of -5.5%. Net debt stands at 10.8M PLN. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Miraculum S.A., a cosmetic company, develops and markets skin and body care, shaving, depilation, perfume, and makeup products for men and women in Poland and internationally. The company offers its products primarily under the JOKO, Miraculum, Pani Walewska, Gracja, Pani Walewska, Gracja, Paloma, Wars, Lider, Tanita, and Chopin, Miraculum, Wars, and Lider brands. The company was founded in 1924 and is headquartered in Warsaw, Poland.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Miraculum S.A reported revenue of 53.7M PLN in FY2025 versus 33.7M PLN in FY2021, a compound +12.4%/yr. Reported net income was −1.5M PLN in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | 2,590 MXN | 1,732 MXN | -33% |
| L'Oréal S.A LRLCF | $428.02 | $273.79 | -36% |
| Unilever PLC UNLYF | $59.34 | $46.11 | -22% |
| Colgate-Palmolive Company CPA | €79.16 | €55.96 | -29% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,185 | ₹1,000 | -54% |
| Reckitt Benckiser Group RBGLY | $12.32 | $17.37 | +41% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Miraculum S.A (MIR) undervalued?
What is the fair value of MIR?
What is the quality score of MIR?
What is the revenue of Miraculum S.A (MIR)?
What is the net profit margin of MIR?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.